Nov 9 (Reuters) - Greenlight Biosciences Holdings PBC
GRNA.O :
* GREENLIGHT BIOSCIENCES ANNOUNCES THIRD QUARTER 2022
FINANCIAL
RESULTS AND HIGHLIGHTS RECENT COMPANY PROGRESS
* GREENLIGHT BIOSCIENCES HOLDINGS PBC- CASH, CASH
EQUIVALENTS, AND
MARKETABLE SECURITIES WERE $98.4 MILLION AS OF SEPTEMBER 30,
2022
* GREENLIGHT BIOSCIENCES HOLDINGS PBC - QTRLY NET LOSS PER
SHARE -
BASIC AND DILUTED $0.27
Source text for Eikon: ID:nGNXbb0x9H
Further company coverage: GRNA.O
((Reuters.Briefs@thomsonreuters.com;))